Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
2024 ISPAD Clinical Practice Consensus Guidelines Update.
Mahmud FH, Dovc K, Marcovecchio ML, Priyambada L, Smart CE, DiMeglio LA. Mahmud FH, et al. Horm Res Paediatr. 2024 Dec 16:1-3. doi: 10.1159/000543154. Online ahead of print. Horm Res Paediatr. 2024. PMID: 39681103 Free article. No abstract available.
ISPAD Clinical Practice Consensus Guidelines 2024: Glycemic Targets.
de Bock M, Agwu JC, Deabreu M, Dovc K, Maahs DM, Marcovecchio ML, Mahmud FH, Nóvoa-Medina Y, Priyambada L, Smart CE, DiMeglio LA. de Bock M, et al. Among authors: mahmud fh. Horm Res Paediatr. 2024 Dec 19:1-13. doi: 10.1159/000543266. Online ahead of print. Horm Res Paediatr. 2024. PMID: 39701064 Free article.
Human acid-labile subunit deficiency: clinical, endocrine and metabolic consequences.
Domené HM, Hwa V, Argente J, Wit JM, Camacho-Hübner C, Jasper HG, Pozo J, van Duyvenvoorde HA, Yakar S, Fofanova-Gambetti OV, Rosenfeld RG; International ALS Collaborative Group. Domené HM, et al. Horm Res. 2009;72(3):129-41. doi: 10.1159/000232486. Epub 2009 Sep 1. Horm Res. 2009. PMID: 19729943 Review.
Association of Fructosamine Levels With Glycemic Management in Children With Type 1 Diabetes as Determined by Continuous Glucose Monitoring: Results From the CGM TIME Trial.
Verbeeten KC, Tang K, Courtney JM, Bradley BJ, McAssey K, Clarson C, Kirsch S, Curtis JR, Mahmud FH, Richardson C, Cooper T, Lawson ML; CGM TIME Trial Study Group; JDRF Canadian Clinical Trials Group. Verbeeten KC, et al. Among authors: mahmud fh. Can J Diabetes. 2024 Jul;48(5):330-336.e2. doi: 10.1016/j.jcjd.2024.04.007. Epub 2024 Apr 16. Can J Diabetes. 2024. PMID: 38614216
Socioeconomic representativeness of Australian, Canadian and British cohorts from the paediatric diabetes AdDIT study: comparisons to regional and national data.
Mahmud FH, Clarke ABM, Elia Y, Curtis J, Benitez-Aguirre P, Cameron FJ, Chiesa ST, Clarson C, Couper JJ, Craig ME, Dalton RN, Daneman D, Davis EA, Deanfield JE, Donaghue KC, Jones TW, Marshall SM, Neil A, Marcovecchio ML. Mahmud FH, et al. BMC Med. 2023 Dec 20;21(1):506. doi: 10.1186/s12916-023-03222-w. BMC Med. 2023. PMID: 38124088 Free PMC article.
Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial.
Laffel LM, Danne T, Klingensmith GJ, Tamborlane WV, Willi S, Zeitler P, Neubacher D, Marquard J; DINAMO Study Group. Laffel LM, et al. Lancet Diabetes Endocrinol. 2023 Mar;11(3):169-181. doi: 10.1016/S2213-8587(22)00387-4. Epub 2023 Feb 1. Lancet Diabetes Endocrinol. 2023. PMID: 36738751 Free PMC article. Clinical Trial.
99 results